Cardiovascular Outcomes and Angiotensin Converting Enzyme Inhibitors: Beyond Blood Pressure Control: Editorial to: “Secondary Prevention of Coronary Disease with ACE Inhibition—Does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA?” by Remme et al.

By Verma Anil   Ventura Hector  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 109-111

Springer Publishing Company

Access to resources Recommend Favorite

Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds?

By Maxwell Donald   Brecht Karen   Koplovitz Irwin   Sweeney Richard  

Archives of Toxicology, Vol. 80, Iss. 11, 2006-11 ,pp. : 756-760

Springer Publishing Company

Access to resources Recommend Favorite

Does Isoform Diversity Explain Functional Differences in the 14-3-3Protein Family?

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 3, 2006-06 ,pp. : 217-223

Bentham Science Publishers

Access to resources Recommend Favorite

Aminophylline does not improve outcomes in cardiac arrest

By  

Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Hypoglycaemia in diabetes

By Macleod Kenneth M.  

Clinical Medicine, Vol. 4, Iss. 4, 2004-07 ,pp. : 307-310

Royal College Of Physicians

Access to resources Recommend Favorite